Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

SELL
$0.28 - $1.16 $12,600 - $52,200
-45,000 Reduced 61.69%
27,943 $9,000
Q3 2023

Nov 13, 2023

BUY
$1.61 - $2.54 $117,438 - $185,275
72,943 New
72,943 $132,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $11.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Mcia Inc Portfolio

Follow Mcia Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mcia Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mcia Inc with notifications on news.